| Issue |
Section |
Title |
File |
| Vol 17, No 3 (2020) |
Reviews |
Non-steroidal anti-inflammatory drugs (NSAIDs) – exacerbated respiratory disease: epidemiology, pathogenesis, clinical findings and management |
(Rus)
|
| Vol 17, No 3 (2020) |
Help to the practitioner |
Efficacy and safety of the antileukotriene drugs: relevant data. RAACI experts conclusion |
(Rus)
|
| Vol 18, No 1 (2021) |
Letters to the editor |
Chronic urticaria in theory and practice. Experience of UCARE-centers for clinicians |
(Rus)
(Eng)
|
| Vol 18, No 3 (2021) |
Clinical practice guidelines |
Vaccination of patients with allergic disease against novel coronavirus infection: position paper of the Russian Association of Allergology and Clinical Immunology |
(Rus)
|
| Vol 18, No 4 (2021) |
Clinical practice guidelines |
Asthma |
(Rus)
|
| Vol 19, No 1 (2022) |
Clinical practice guidelines |
Allergic rhinitis |
(Rus)
|
| Vol 19, No 2 (2022) |
Reviews |
Allergen-specific immunotherapy and real-world evidence |
(Rus)
|
| Vol 19, No 2 (2022) |
Original studies |
Omalizumab in the severe exacerbations of seasonal allergic rhinitis |
(Rus)
(Eng)
|
| Vol 19, No 2 (2022) |
Reviews |
Combination therapy of allergic rhinitis: efficacy, safety and impact on quality of life |
(Rus)
|
| Vol 19, No 3 (2022) |
Reviews |
Molecular allergology place in allergen-specific immunotherapy |
(Rus)
|
| Vol 20, No 2 (2023) |
Reviews |
Searching for predictive biomarkers of allergen-specific immunotherapy efficacy based on modern concepts of its mechanisms |
(Rus)
(Eng)
|
| Vol 20, No 2 (2023) |
Clinical practice guidelines |
Leukotriene receptor antagonists in the treatment of bronchial asthma: Consensus agreement “Bronchial Asthma and LEukoTriene receptor antagonists (BALET)” |
(Rus)
|
| Vol 21, No 1 (2024) |
Short communications |
Potential of the domestic biosimile omalizumab in achievement of control in patients with severe asthma: short communication |
(Rus)
|
| Vol 22, No 1 (2025) |
Case reports |
Possibilities of achieving control of allergic rhinitis in a patient with skin sensitization and continued contact with pets |
(Rus)
|
| Vol 22, No 2 (2025) |
Reviews |
Current aspects of the use of allergen-specific immunotherapy in patients with bronchial asthma: review of GINA 2024 updates and results of the EfficAPSI study |
(Rus)
|
| Vol 22, No 2 (2025) |
Letters to the editor |
The past, present, and future of anti-IgE therapy |
(Rus)
|
| Vol 22, No 3 (2025) |
Original studies |
Evaluation of the concentration dynamics of allergen-specific secretory immunoglobulin A in saliva, interleukin 4 and interferon γ in blood serum as predictive biomarkers of the allergen immunotherapy efficacy |
|
